SynthesisBMC infectious diseases2026
Impact of flooding events on waterborne and vector-borne infections: a systematic review.
Synthesis in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development of DuoChol, a Thermostable Inactivated Whole-Cell/B-Subunit Oral Cholera Vaccine in Enteric Capsule.Vaccines · 2026Article
- Anticipating El Niño-related health risks in Latin America and the Caribbean: from climate information to public health preparedness.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFlooding from natural disasters has become increasingly common worldwide, increasing the risk of infectious disease transmission, particularly waterborne and vector-borne infections. Although many studies report outbreaks following floods, the evidence remains fragmented across regions and pathogens. A comprehensive review is needed to clarify these associations and inform effective prevention and response strategies.
methodsA systematic search of PubMed, Embase, and the Cochrane Library was conducted between November 2024 and January 2025, identifying studies published from January 1, 2014, to December 31, 2024. Eligible studies assessed the association between flooding and waterborne or vector-borne infections and their health outcomes or evaluated related prevention and response interventions. Data were synthesized narratively due to study heterogeneity.
resultsOf the 1,785 records identified, 71 studies met the inclusion criteria. Flooding was consistently associated with increased incidence of waterborne infections, including leptospirosis, cholera, bacillary dysentery, and hepatitis A/E, as well as vector-borne infections such as dengue and malaria. Outbreaks varied by region, flood characteristics, and the strength of existing public health infrastructure. The lag period between the onset of flooding and disease emergence ranged from days to weeks. Timely interventions such as chemoprophylaxis, vaccination, water, sanitation, and hygiene (WASH) measures, and vector control may help mitigate outbreaks; however, most included studies were observational in design, and the overall certainty of evidence was low to moderate. Data on health system impacts, including hospitalization rates, intensive care unit burden, and mortality stratified by level of care, remain limited.
conclusionFlooding was most frequently associated with increased incidence of cholera, bacillary dysentery, leptospirosis, dengue, and malaria, each with distinct lag periods critical for outbreak prediction. Reported lag periods ranged from days to weeks. Limited observational evidence suggests that doxycycline chemoprophylaxis for leptospirosis, oral cholera vaccination, and early vector control may be useful in selected post-flood settings. These findings support strengthened post-flood surveillance and context-specific preparedness measures, while highlighting the need for higher-quality comparative studies. REGISTRATION: PROSPERO CRD42025635687. CLINICAL TRIAL NUMBE: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.